Local microwave hyperthermia in the treatment of carcinoma of the prostate. 1986

A Yerushalmi, and A Shani, and Y Fishelovitz, and J Arielly, and D Singer, and E Levy, and R Katsnelson, and E Rakowsky, and J A Stein

The clinical electromagnetic hyperthermia system has been in use at the Kaplan Hospital since 1980, for treating patients with hyperthermia combined with radio- or chemotherapy. For prostatic tumors, hyperthermia at 43 degrees C is achieved in the prostatic mass using microwaves of 2.45 GHz, with simultaneous cooling of the rectal mucosa and the rectal wall. Thirty-two patients with carcinoma of the prostate have been treated: 4 with heat alone, 20 with hyperthermia combined with radiotherapy, and 8 with hyperthermia combined with hormonal therapy. Follow-up was carried out up to 34 months. Objective local tumor regression was achieved in 3 out of 4 patients treated by heat alone, but the patients relapsed after 6 months. All the 20 patients treated with combined hyperthermia and radiotherapy responded to treatment. Patients treated with combined hyperthermia and hormone therapy responded locally to treatment but died of their metastatic disease, or of unrelated diseases with a follow-up period up to 31 months. Hyperthermia did not increase morbidity beyond that expected for radiation therapy.

UI MeSH Term Description Entries
D006979 Hyperthermia, Induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Yerushalmi, and A Shani, and Y Fishelovitz, and J Arielly, and D Singer, and E Levy, and R Katsnelson, and E Rakowsky, and J A Stein
August 1987, Urology,
A Yerushalmi, and A Shani, and Y Fishelovitz, and J Arielly, and D Singer, and E Levy, and R Katsnelson, and E Rakowsky, and J A Stein
April 1982, Zhonghua fu chan ke za zhi,
A Yerushalmi, and A Shani, and Y Fishelovitz, and J Arielly, and D Singer, and E Levy, and R Katsnelson, and E Rakowsky, and J A Stein
January 1986, The Prostate,
A Yerushalmi, and A Shani, and Y Fishelovitz, and J Arielly, and D Singer, and E Levy, and R Katsnelson, and E Rakowsky, and J A Stein
January 1982, The Prostate,
A Yerushalmi, and A Shani, and Y Fishelovitz, and J Arielly, and D Singer, and E Levy, and R Katsnelson, and E Rakowsky, and J A Stein
April 1990, British journal of urology,
A Yerushalmi, and A Shani, and Y Fishelovitz, and J Arielly, and D Singer, and E Levy, and R Katsnelson, and E Rakowsky, and J A Stein
January 1988, Urological research,
A Yerushalmi, and A Shani, and Y Fishelovitz, and J Arielly, and D Singer, and E Levy, and R Katsnelson, and E Rakowsky, and J A Stein
January 1992, The Prostate,
A Yerushalmi, and A Shani, and Y Fishelovitz, and J Arielly, and D Singer, and E Levy, and R Katsnelson, and E Rakowsky, and J A Stein
December 1989, Clinical rheumatology,
A Yerushalmi, and A Shani, and Y Fishelovitz, and J Arielly, and D Singer, and E Levy, and R Katsnelson, and E Rakowsky, and J A Stein
November 1980, International journal of radiation oncology, biology, physics,
A Yerushalmi, and A Shani, and Y Fishelovitz, and J Arielly, and D Singer, and E Levy, and R Katsnelson, and E Rakowsky, and J A Stein
March 1995, The Journal of urology,
Copied contents to your clipboard!